{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:19:35Z","timestamp":1790734775746,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009169","name":"Assiut University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009169","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Systemic inflammatory response syndrome (SIRS) is a systemic insult that has been described with many interventional cardiac procedures. The outcomes of patients undergoing transcatheter aortic valve implantation (TAVI) are thought to be influenced by this syndrome not only on short-term, but also on long-term.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We assessed the association of SIRS to different clinical, echocardiographic, and computed tomographic (CT) outcomes after TAVI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Two hundred and twenty-four consecutive patients undergoing TAVI were enrolled in this study. They were assessed for the occurrence of SIRS within the first 48 h after TAVI. Patients were followed-up for short- and long-term clinical outcomes. Serial echocardiographic follow-ups were conducted at 1-week, 6-months, and 1-year. CT follow-up at 1 year was recorded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighty patients (36%) developed SIRS. Among different parameters, only pre-TAVI total leucocytic count (TLC), pre-TAVI heart rate, and post-TAVI systolic blood pressure independently predicted the occurrence of SIRS. The incidence of HALT was not significantly different between both groups, albeit higher among SIRS patients (<jats:italic>p<\/jats:italic> = 0.1) at 1-year CT follow-up. Both groups had similar patterns of LV recovery on serial echocardiography. Long-term follow-up showed that all-cause death, cardiac death, and re-admission for heart failure (HF) or acute coronary syndrome (ACS) were significantly more frequent among SIRS patients. Early safety and clinical efficacy outcomes were more frequently encountered in the SIRS group, while device-related events and time-related valve safety were comparable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although SIRS implies an early acute inflammatory status post-TAVI, yet its clinical sequelae seem to extend to long-term clinical outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2021.746774","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T06:18:52Z","timestamp":1644387532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of Systemic Inflammatory Response Syndrome on Clinical, Echocardiographic, and Computed Tomographic Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation"],"prefix":"10.3389","volume":"8","author":[{"given":"Tarek A. N.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Jeong","family":"Ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"El-Naggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeehoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Kyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Mo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bon-Kwon","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.amjcard.2004.11.008","article-title":"Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)","volume":"95","author":"Patel","year":"2005","journal-title":"Am J Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/eurheartj\/ehi292","article-title":"Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial","volume":"26","author":"Th\u00e9roux","year":"2005","journal-title":"Eur Heart J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1016\/j.ijcard.2013.08.040","article-title":"Impact of inflammatory process on left ventricular recovery after Transcatheter Aortic Valve Implantation","volume":"168","author":"Vavuranakis","year":"2013","journal-title":"Int J Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1345\/aph.1D203","article-title":"Role of C-Reactive protein in cardiovascular disease","volume":"38","author":"Backes","year":"2004","journal-title":"Ann Pharmacother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jcmg.2017.02.005","article-title":"Systematic CT methodology for the evaluation of subclinical leaflet thrombosis","volume":"10","author":"Jilaihawi","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/ehjci\/jeaa184","article-title":"Quantification of hypo-attenuated leaflet thickening after transcatheter aortic valve implantation: clinical relevance of hypo-attenuated leaflet thickening volume","volume":"21","author":"Kar\u00e1dy","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/eurheartj\/ehs002","article-title":"Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation","volume":"33","author":"Sinning","year":"2012","journal-title":"Eur Heart J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1213\/00000539-199710000-00011","article-title":"The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations","volume":"85","author":"Hall","year":"1997","journal-title":"Anesth Analg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ejcts.2005.07.007","article-title":"Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know?","volume":"28","author":"Franke","year":"2005","journal-title":"Eur J Cardiothorac Surg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1378\/chest.113.5.1290","article-title":"Systemic inflammation present in patients undergoing CABG without extracorporeal circulation","volume":"113","author":"Fransen","year":"1998","journal-title":"Chest."},{"key":"B11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.4070\/kcj.2018.0117","article-title":"Trends and outcomes of transcatheter aortic valve implantation (TAVI) in Korea: the results of the first cohort of Korean TAVI registry","volume":"48","author":"Yu","year":"2018","journal-title":"Korean Circ J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","author":"Bone","year":"","journal-title":"Chest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jama.1995.03520260039030","article-title":"The natural history of the Systemic Inflammatory Response Syndrome (SIRS): a prospective study","volume":"273","author":"Rangel Frausto","year":"1995","journal-title":"JAMA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research Consortium-2 consensus document","volume":"33","author":"Kappetein","year":"2012","journal-title":"Eur Heart J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1056\/NEJMoa1509233","article-title":"Possible subclinical leaflet thrombosis in bioprosthetic aortic valves","volume":"373","author":"Makkar","year":"2015","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmg.2018.12.003","article-title":"Computed tomography imaging in the context of Transcatheter Aortic Valve Implantation (TAVI)\/Transcatheter Aortic Valve Replacement (TAVR): an expert consensus document of the society of cardiovascular computed tomography","volume":"12","author":"Blanke","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.4244\/EIJY14M06_05","article-title":"Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves","volume":"10","author":"Schwietz","year":"2015","journal-title":"EuroIntervention."},{"key":"B19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/heartjnl-2014-307057","article-title":"Systemic inflammatory response syndrome after transcatheter or surgical aortic valve replacement","volume":"101","author":"Lindman","year":"2015","journal-title":"Heart."},{"key":"B20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/026765919901400406","article-title":"Mechanisms of the systemic inflammatory response","volume":"14","author":"Asimakopoulos","year":"1999","journal-title":"Perfusion"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1001\/archinte.165.14.1643","article-title":"Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock","volume":"165","author":"Kohsaka","year":"2005","journal-title":"Arch Intern Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1161\/01.CIR.0000075927.67673.F2","article-title":"Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm","volume":"107","author":"Hochman","year":"2003","journal-title":"Circulation."},{"key":"B23","first-page":"53","article-title":"In-vitro investigation of the hemodynamics of the Edwards SapienTM transcatheter heart valve","volume":"20","author":"St\u00fchle","year":"2011","journal-title":"J Heart Valve Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIRCRESAHA.108.188243","article-title":"IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR","volume":"104","author":"Krishnamurthy","year":"2009","journal-title":"Circ Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1093\/eurheartj\/ehv526","article-title":"Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves","volume":"37","author":"Pache","year":"2016","journal-title":"Eur Heart J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmg.2016.11.005","article-title":"Incidence, predictors, and mid-term outcomes of possible leaflet thrombosis after TAVR","volume":"10","author":"Yanagisawa","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.jacc.2016.08.010","article-title":"Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications","volume":"68","author":"Hansson","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"389","author":"Chakravarty","year":"2017","journal-title":"Lancet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jacc.2017.07.715","article-title":"Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration","volume":"70","author":"Rodriguez-Gabella","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1523-1755.2004.00512.x","article-title":"Plasma cytokine levels predict mortality in patients with acute renal failure","volume":"65","author":"Simmons","year":"2004","journal-title":"Kidney Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1186\/cc7940","article-title":"Serum Interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study","volume":"13","author":"Liu","year":"2009","journal-title":"Crit Care."},{"key":"B34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/01.CCM.0000104951.94820.A9","article-title":"Transfusion-related leukocytosis in critically ill patients","volume":"32","author":"Izbicki","year":"2004","journal-title":"Crit Care Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.698977","article-title":"Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery","volume":"116","author":"Murphy","year":"2007","journal-title":"Circulation."},{"key":"B36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/CIRCRESAHA.118.313129","article-title":"Anticytokine agents: targeting interleukin signaling pathways for the treatment of atherothrombosis","volume":"124","author":"Ridker","year":"2019","journal-title":"Circ Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-Dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1002\/ehf2.12837","article-title":"Inflammatory signatures are associated with increased mortality after transfemoral transcatheter aortic valve implantation","volume":"7","author":"Hoffmann","year":"2020","journal-title":"ESC Heart Fail."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.746774\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T06:18:56Z","timestamp":1644387536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.746774\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":39,"alternative-id":["10.3389\/fcvm.2021.746774"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.746774","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"article-number":"746774"}}